| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 19/07/2022 | 13:30 | RNS Non-Regulatory | Keras Resources PLC Update regarding Investor Presentation and GM | LSE:FRX | Ferrex |
| 22/06/2022 | 16:20 | RNS Non-Regulatory | Keras Resources PLC New Date - Shareholder/Investor Presentation | LSE:FRX | Ferrex |
| 09/06/2022 | 08:03 | RNS Non-Regulatory | Keras Resources PLC Shareholder/Investor Meeting and Presentation | LSE:FRX | Ferrex |
| 24/06/2021 | 15:36 | RNS Non-Regulatory | Keras Resources PLC Updated Corporate Presentation | LSE:FRX | Ferrex |
| 30/10/2019 | 08:00 | RNS Non-Regulatory | Keras Resources PLC Joint Investor Event - Further Details | LSE:FRX | Ferrex |
| 14/09/2018 | 13:00 | RNS Non-Regulatory | Keras Resources PLC Investor Event | LSE:FRX | Ferrex |
| 23/11/2017 | 16:55 | RNS Non-Regulatory | Keras Resources PLC New Company Presentation | LSE:FRX | Ferrex |
| 16/11/2017 | 10:47 | RNS Non-Regulatory | Keras Resources PLC Pilbara Gold Presentation-London 23 November 2017 | LSE:FRX | Ferrex |
| 01/08/2017 | 08:02 | RNS Non-Regulatory | Keras Resources PLC Brandon Hill Research | LSE:FRX | Ferrex |
| 12/04/2016 | 13:20 | RNS Non-Regulatory | Keras Resources PLC New Corporate Presentation | LSE:FRX | Ferrex |
| 18/03/2016 | 08:00 | RNS Non-Regulatory | Keras Resources PLC Corporate Presentation | LSE:FRX | Ferrex |
| 29/10/2009 | 10:54 | Dow Jones News | Richter To Start Late Stage Tests On Key Schizophrenia Drug | NYSE:FRX | Forest Laboratories Inc. |
| 29/10/2009 | 09:47 | Dow Jones News | Hungary Richter, US Forest Announce Positive Drug Tests | NYSE:FRX | Forest Laboratories Inc. |
| 28/08/2009 | 00:31 | PR Newswire (US) | Four Studies Published in The Lancet Show roflumilast (Daxas(R)), a New Oral Approach to COPD, Improves Lung Function and Reduce | NYSE:FRX | |
| 19/08/2009 | 15:50 | Dow Jones News | 2nd UPDATE: Glenmark, Forest Say Their Drug Failed In Trials | NYSE:FRX | Forest Laboratories Inc. |
| 19/08/2009 | 09:53 | Dow Jones News | UPDATE: Glenmark, Forest Say Oglemilast Failed In Key Study | NYSE:FRX | Forest Laboratories Inc. |
| 12/08/2009 | 10:32 | Dow Jones News | AstraZeneca, Forest Labs Ink Ceftaroline Deal | NYSE:FRX | Forest Laboratories Inc. |
| 10/08/2009 | 13:00 | PR Newswire (US) | Nycomed and Forest Laboratories to Collaborate on US Commercialisation of Daxas(R) in COPD | NYSE:FRX | |
| 21/07/2009 | 15:08 | Dow Jones News | Forest Labs 1Q Net Up 8.2% As Namenda Sales Jump | NYSE:FRX | Forest Laboratories Inc. |
| 22/06/2009 | 15:20 | PR Newswire (US) | Beacon Equity Research on Stocks to Watch: Forest Labs, Harris, Philip Morris, IAMGOLD, Steel Dynamics and Wyndham | NYSE:FRX | |
| 19/06/2009 | 20:40 | Dow Jones News | Forest Labs Reports Upbeat Pneumonia Drug Test Results | NYSE:FRX | Forest Laboratories Inc. |
| 10/06/2009 | 16:54 | Dow Jones News | PHARMA MARKET: Wyeth Stands By Pristiq After Slow Start | NYSE:FRX | Forest Laboratories Inc. |
| 22/05/2009 | 22:34 | Dow Jones News | Drug Makers To Pay $89 Million To Settle Alabama Medicaid Price Suits | NYSE:FRX | Forest Laboratories Inc. |
| 05/05/2009 | 17:03 | Dow Jones News | 2nd UPDATE:Jubilant Organosys Unit In Pact With AstraZeneca | NYSE:FRX | Forest Laboratories Inc. |
| 30/04/2009 | 10:01 | Dow Jones News | Almirall, Forest See New Drug Application For COPD By 2012 | NYSE:FRX | Forest Laboratories Inc. |
| 21/04/2009 | 15:09 | Dow Jones News | Forest Labs 4Q Net Drops 46% Amid Marketing Probe Set-Aside | NYSE:FRX | Forest Laboratories Inc. |
| 04/04/2009 | 01:34 | Dow Jones News | UPDATE: FDA Warns World's Largest Drug Firms Over Internet Ads | NYSE:FRX | Forest Laboratories Inc. |
| 04/04/2009 | 00:22 | Dow Jones News | FDA Warns World's Largest Drug Firms Over Internet Ads | NYSE:FRX | Forest Laboratories Inc. |
| 06/03/2009 | 13:21 | Dow Jones News | FDA Wants More Study On Almirall, Forest Labs COPD Drug | NYSE:FRX | Forest Laboratories Inc. |
| 25/02/2009 | 23:24 | Dow Jones News | UPDATE:DOJ:Forest Labs Engaged In Improper Marketing,Kickbacks | NYSE:FRX | Forest Laboratories Inc. |
